Info Obat dan Regulator Obat Dunia

E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022 , PRAC, 02/09/2022
Replies
0
Views
521
EMA
E
E
Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan, , 30/08/2022
Replies
0
Views
253
EMA
E
E
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines, , 06/09/2022
Replies
0
Views
251
EMA
E
F
Tramadol US - 634444 - 08/16/2022
Replies
0
Views
345
FDA
F
F
Best Practices for Utilizing Modeling Approaches to Support Generic Product Development - 10/27/2022
Replies
0
Views
260
FDA
F
F
2019 Meeting Materials Pharmaceutical Science and Clinical Pharmacology Advisory Committee
Replies
0
Views
224
FDA
F
F
An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs – General Considerations - 10/26/2022
Replies
0
Views
418
FDA
F
F
Antibacterial Susceptibility Test Interpretive Criteria
Replies
0
Views
262
FDA
F
F
Oncologic Drugs Advisory Committee Charter
Replies
0
Views
314
FDA
F
F
2019 Meeting Materials, Endocrinologic and Metabolic Drugs Advisory Committee
Replies
0
Views
239
FDA
F
F
Charging for Investigational Drugs Under an IND: Questions and Answers
Replies
0
Views
248
FDA
F
F
Challenges and Opportunities for REMS Integration, Innovation, and Modernization - 10/11/2022
Replies
0
Views
281
FDA
F
F
Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (Containing Benzyl Alcohol), Due To The Potential Presence of
Replies
0
Views
274
FDA
F
E
EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox , , 19/08/2022
Replies
0
Views
438
EMA
E
F
Tainted Sleep Aid Products
Replies
0
Views
326
FDA
F
F
Tainted Arthritis | Pain Products
Replies
0
Views
330
FDA
F
F
Interpreting Why FDA Returned Your Electronic Certificate of Pharmaceutical Product Application
Replies
0
Views
315
FDA
F
F
Electronic Certificates of Pharmaceutical Product: General Information
Replies
0
Views
278
FDA
F
F
FDA alerts patients, caregivers, and health care providers of cross-compatibility issues with autoinjector devices that are optional for use with glat
Replies
0
Views
233
FDA
F
E
EMA starts review of conditional marketing authorisation application for Skycovion COVID-19 vaccine, CHMP, 18/08/2022
Replies
0
Views
259
EMA
E
You must log in or register to post here.
Top